Across TCGA pan-cancer cohorts, CDRT15P11 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of CDRT15P11’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where CDRT15P11 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CDRT15P11 is over-expressed in tumor.
LUSC are the cancer types where CDRT15P11 tumor–normal differential expression is most reproducible.